Insulin receptor substrate-4 enhances insulin-like growth factor-I-induced cell proliferation

被引:51
作者
Qu, BH [1 ]
Karas, M [1 ]
Koval, A [1 ]
LeRoith, D [1 ]
机构
[1] NIDDK, Clin Endocrinol Branch, NIH, Sect Mol & Cellular Physiol, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.274.44.31179
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The insulin receptor substrates (IRSs)-1-4 play important roles in signal transduction emanating from the insulin and insulin-like growth factor (IGF)-I receptors. IRS-4 is the most recently characterized member, which has been found primarily in human cells and tissues. It interacts with SH2-containing proteins such ars phosphatidylinositol 3'-kinase (PI3K), Grb2, Crk-II, and CrkL. In this study, we transfected IRS-4 in mouse NIH-3T3 cells that overexpress IGF-I receptors. Clones expressing IRS-4 showed enhanced cellular proliferation when cells were cultured in 1% fetal bovine serum without added IGF-I. Addition of IGF-I enhanced cellular proliferation in cells overexpressing the IGF-I receptor alone but had an even greater proliferative effect in cells overexpressing both the IGF-I receptors and IRS-4. When etoposide and methylmethane sulfonate (MMS), both DNA damaging agents, were added to the cells, they uniformly induced cell cycle arrest. Fluorescence-activated cell sorter analysis demonstrated that the arrest of the cell cycle occurred at the G(1) checkpoint, and furthermore no significant degree of apoptosis was demonstrated with the use of either agent. In cells, overexpressing IGF-I receptors alone, IG;F-I addition enhanced cellular proliferation, even in the presence of etoposide and MMS. In cells overexpressing IGF-I receptors and IRS-4, the effect of IGF-I in overcoming the cell cycle arrest was even more pronounced. These results suggest that IRS-4 is implicated in the IGF-I receptor mitogenic signaling pathway.
引用
收藏
页码:31179 / 31184
页数:6
相关论文
共 30 条
[1]   MUTATION OF A CONSERVED AMINO-ACID RESIDUE (TRYPTOPHAN-1173) IN THE TYROSINE KINASE DOMAIN OF THE IGF-I RECEPTOR ABOLISHES AUTOPHOSPHORYLATION BUT DOES NOT ELIMINATE BIOLOGIC FUNCTION [J].
BLAKESLEY, VA ;
KATO, H ;
ROBERTS, CT ;
LEROITH, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) :2764-2769
[2]   Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles [J].
Bruning, JC ;
Winnay, J ;
BonnerWeir, S ;
Taylor, SI ;
Accili, D ;
Kahn, CR .
CELL, 1997, 88 (04) :561-572
[3]   Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide [J].
Chen, G ;
Shu, JY ;
Stacey, DW .
ONCOGENE, 1997, 15 (14) :1643-1651
[4]   Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor [J].
Eck, MJ ;
DhePaganon, S ;
Trub, T ;
Nolte, RT ;
Shoelson, SE .
CELL, 1996, 85 (05) :695-705
[5]   Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cells [J].
Fantin, VR ;
Sparling, JD ;
Slot, JW ;
Keller, SR ;
Lienhard, GE ;
Lavan, BE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (17) :10726-10732
[6]   Cloning, tissue expression, and chromosomal location of the mouse insulin receptor substrate 4 gene [J].
Fantin, VR ;
Lavan, BE ;
Wang, Q ;
Jenkins, NA ;
Gilbert, DJ ;
Copeland, NG ;
Keller, SR ;
Lienhard, GE .
ENDOCRINOLOGY, 1999, 140 (03) :1329-1337
[7]   A Grb2-associated docking protein in EGF- and insulin-receptor signalling [J].
HolgadoMadruga, M ;
Emlet, DR ;
Moscatello, DK ;
Godwin, AK ;
Wong, AJ .
NATURE, 1996, 379 (6565) :560-564
[8]  
Ito T, 1996, MOL CELL BIOL, V16, P943
[9]   Interplay of the proto-oncogene proteins CrkL and CrkII in insulin-like growth factor-I receptor-mediated signal transduction [J].
Koval, AP ;
Karas, M ;
Zick, Y ;
LeRoith, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (24) :14780-14787
[10]  
Kuo ML, 1997, MOL CARCINOGEN, V18, P221, DOI 10.1002/(SICI)1098-2744(199704)18:4<221::AID-MC6>3.0.CO